Aptamers Market Size to Reach USD 17.4 Billion by 2032 | Straits Research

The global Aptamers Market was valued at USD 2.3 billion in 2023 and is projected to expand from USD 2.9 billion in 2024 to USD 17.4 billion by 2032, registering a remarkable compound annual growth rate (CAGR) of 24.8% during the forecast period of 2024–2032, according to a recent report by Straits Research.

Aptamers, which are short single-stranded nucleic acids or peptides, are being increasingly adopted in a range of applications including diagnostics, therapeutics, and research and development. This surge in adoption is primarily driven by the significant advantages offered by aptamers over traditional antibodies, such as their smaller size, ease of production, and higher stability under various conditions. These properties make aptamers ideal for use in diagnostics and treatment applications, as well as in research environments where precision and reliability are key.

Request a Free Sample (Free Executive Summary at Full Report Starting from USD 185: https://straitsresearch.com/re....port/aptamers-market